Cure My Disease

Don't miss your cure!

 Log in / Sign up

Electric pulses to nerves: a new test for pain relief

NCT ID NCT06717789

Symptom relief Sponsor: DJO UK Ltd Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 28, 2026 · Last updated Aug 28, 2026

Summary

This study tests whether a device called Compex SP8.0, which sends mild electrical pulses through the skin to stimulate sensory nerves, can reduce musculoskeletal pain. Adults with pain rated 4 or higher on a 0-10 scale will use the device's pain management programs at home for up to 4 weeks. Researchers will measure changes in pain scores and track any side effects. The goal is to see if this drug-free approach offers meaningful pain relief.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Transcutaneous Electrical Nerve Stimulation (TENS) using the Compex SP8.0 device
What this could lead to
If it works, this could support the use of TENS as a drug-free option for managing musculoskeletal pain and help validate a next-generation wireless device.
What could go wrong
This is a post-market study, not a large randomized trial, so results may not apply broadly. Pain relief may vary, and there is a small risk of skin irritation or discomfort from the electrical stimulation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

74 people

The number who actually took part.

Started

Apr 2025

Finished

Dec 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Adult subjects currently experiencing musculoskeletal pain with a Numeric Pain Rating Scale (NPRS) score of 4 or more at baseline. 2. Subjects are considered suitable to self-administer stimulation of motor nerves or stimulation of sensory nerves at home, based on the Investigator's judgement. 3. Subjects are suitable to receive treatment using the Compex SP8.0 device Pain management programs (pre-set parameters) for up to 4 weeks, based on the Investigator's judgement. 4. Subject, both male and female, ≥ 18 years of age at the time of consent 5. Subject has reviewed the IEC-approved consent form, has properly consented per the protocol and has documented their consent to participate in the study by signing the Ethics-approved consent form. 6. Subject does not meet any of the exclusion criteria Exclusion Criteria: 1. Pregnancy 2. Presence of Implanted electronic devices (e.g., pacemakers, defibrillators) 3. Skin conditions that contraindicate TENS use (e.g., rashes, wounds in electrode placement areas). 4. Known allergy to electrode materials. 5. Current participation in another clinical study that could interfere with this study's outcomes. 6. Subjects who are not able to read and understand the Instructions for Use, warnings, cautions and dangers 7. Subjects who are not able to read and understand indications and contraindications of the device 8. Subjects who are not able to sense auditory and visual signals 9. Subjects who are being treated with any other electrotherapy device for pain relief. 10. Subjects who are being treated with acupuncture 11. Participation in another clinical study within 30 days prior to screening

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Musculoskeletal conditions are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Musculoskeletal Pain musculoskeletal system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Musculoskeletal conditions Musculoskeletal pain

Contacts and locations

Locations

  • Salford University Sports Injury Clinic

    Salford, Manchester, M6 6PU, United Kingdom

  • Worsley Physiotherapy and Sports Injuries Clinic

    Worsley, Manchester, M28 2JL, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.